Ameriprise’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-20,199	Closed	-$62K	–	3744
2020 Q2	$62K	Buy	+20,199	New	+$62K	﹤0.01%	3609
2014 Q3	–	Sell	-40	Closed	-$1K	–	5777
2014 Q2	$1K	Buy	+40	New	+$1K	﹤0.01%	5312